TippingPoint BiosciencesTippingPoint Biosciences
TippingPoint Biosciences

TippingPoint Biosciences

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Website
2021Active7
Advertise here

About

TippingPoint Biosciences is a biotechnology company focused on discovering and developing innovative antibody-based therapeutics for cancer. Their approach leverages advanced platform technologies to identify and engineer antibodies with enhanced efficacy and safety profiles. The company aims to address unmet needs in various oncology indications.

Technology stack

detected 2026-06-18
Est. monthly stack spend~$70/mo
CDN
Cloudflare
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does TippingPoint Biosciences do?

TippingPoint Biosciences is a biotechnology company focused on discovering and developing innovative antibody-based therapeutics for cancer. Their approach leverages advanced platform technologies to identify and engineer antibodies with enhanced efficacy and safety profiles. The company aims to address unmet needs in various oncology indications.

How much funding has TippingPoint Biosciences raised?

TippingPoint Biosciences has raised a total of $15M in funding. The most recent round on record is Seed.

Where is TippingPoint Biosciences headquartered?

TippingPoint Biosciences is headquartered in Cambridge, Massachusetts, USA.

When was TippingPoint Biosciences founded?

TippingPoint Biosciences was founded in 2021.

What industry does TippingPoint Biosciences operate in?

TippingPoint Biosciences operates in Biotech, Drug Discovery, Antibody Therapeutics, Oncology, Genomics, Therapeutics.

How many employees does TippingPoint Biosciences have?

TippingPoint Biosciences has approximately 7 people on record.